Daniel R. Budman
Impact in
Papers in
- Oncology 87
- Cancer Treatment and Pharmacology 39
- HER2/EGFR in Cancer Research 16
-
- Cancer therapeutics and mechanisms 14
- Co-authors
- Willi Kreis (25 shared papers)Donald A. Berry (9 shared papers)Constance Cirrincione (7 shared papers)Hyman B. Muss (9 shared papers)Stuart M. Lichtman (19 shared papers)Philip Schulman (24 shared papers)Steven L. Allen (21 shared papers)Larry Norton (8 shared papers)
- Journals
- Journal of Clinical Oncology (23 papers)Cancer Chemotherapy and Pharmacology (11 papers)Cancer Investigation (8 papers)Anti-Cancer Drugs (6 papers)Cancer (6 papers)
- Partner nations
- United StatesUnited KingdomChina
In The Last Decade
Daniel R. Budman
162 papers receiving 10.1k citations
Daniel R. Budman's Hit Papers
Peers
Comparison fields: 5 of 144
- Genetics 2.7k
- Oncology 5.1k
- Pathology and Forensic Medicine 2.3k
- Cancer Research 1.8k
- Immunology 1.9k
Countries citing papers authored by Daniel R. Budman
This map shows the geographic impact of Daniel R. Budman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel R. Budman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel R. Budman more than expected).
Fields of papers citing papers by Daniel R. Budman
This network shows the impact of papers produced by Daniel R. Budman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel R. Budman. The network helps show where Daniel R. Budman may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel R. Budman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 165 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ig V Gene Mutation Status and CD38 Expression As Novel Prognostic Indicators in Chronic Lymphocytic Leukemia Hit paper breakdown → | 1999 | 1897 |
| 2 | c-erbB-2 Expression and Response to Adjuvant Therapy in Women with Node-Positive Early Breast Cancer Hit paper breakdown → | 1994 | 779 |
| 3 | Estrogen-Receptor Status and Outcomes of Modern Chemotherapy for Patients With Node-Positive Breast Cancer Hit paper breakdown → | 2006 | 518 |
| 4 | 1998 | 472 | |
| 5 | 1998 | 466 | |
| 6 | 1999 | 330 | |
| 7 | 2005 | 272 | |
| 8 | 2007 | 248 | |
| 9 | 1989 | 247 | |
| 10 | 2002 | 241 | |
| 11 | 1998 | 221 | |
| 12 | 2001 | 207 | |
| 13 | 1977 | 172 | |
| 14 | 1995 | 159 | |
| 15 | 1977 | 159 | |
| 16 | 2007 | 158 | |
| 17 | 2000 | 158 | |
| 18 | 1996 | 143 | |
| 19 | 1999 | 135 | |
| 20 | 2018 | 124 |
About Daniel R. Budman
Daniel R. Budman is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Genetics, having authored 165 papers that have together received 10.5k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (39 papers), Chronic Lymphocytic Leukemia Research (18 papers), Breast Cancer Treatment Studies (18 papers), HER2/EGFR in Cancer Research (16 papers), Lymphoma Diagnosis and Treatment (16 papers), Acute Myeloid Leukemia Research (15 papers), Cancer therapeutics and mechanisms (14 papers) and Lung Cancer Treatments and Mutations (12 papers). The work is most often cited by research in Genetics (2.7k citations), Oncology (5.1k citations), Pathology and Forensic Medicine (2.3k citations), Cancer Research (1.8k citations) and Immunology (1.9k citations). Daniel R. Budman has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Willi Kreis, Donald A. Berry, Constance Cirrincione, Hyman B. Muss, Stuart M. Lichtman, Philip Schulman, Steven L. Allen, Larry Norton, I. Craig Henderson and Nicholas Chiorazzi. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Cancer Investigation, Anti-Cancer Drugs and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.